In vivo lysogenization of a Clostridium difficile bacteriophage ΦCD119

被引：25

作者：

Govind, Revathi ^{[1
,2
]}

Fralick, Joe A. ^{[2
]}

Rolfe, Rial D. ^{[2
]}

机构：

[1] Kansas State Univ, Div Biol, Manhattan, KS 66506 USA

[2] Texas Tech Univ Hlth Sci Ctr, Dept Microbiol & Immunol, Lubbock, TX 79430 USA

来源：

ANAEROBE | 2011年 / 17卷 / 03期

关键词：

Clostridium difficile; Bacteriophage; Lysogenization; MOLECULAR CHARACTERIZATION; TOXIN SYNTHESIS; GENOME; STRAINS; PATHOGENICITY; ANTIBIOTICS; EVOLUTION; INFECTION; PHAGES; GENE;

D O I：

10.1016/j.anaerobe.2011.05.012

中图分类号：

Q93 [微生物学];

学科分类号：

071005 ; 100705 ;

摘要：

Clostridium difficile is a nosocomial pathogen identified as the cause of antibiotic-associated diarrhea and colitis. In this study, we have documented the lysogeny of a C difficile bacteriophage in hamsters during C difficile infection. The lysogens isolated from the hamsters were toxin typed and their phage integration site was confirmed by PCR Through toxin ELISA it was found that the toxin production in the in vivo isolated lysogens was affected due to Phi CD119 lysogenization as in the case of in vitro isolated Phi CD119 lysogens. Together our findings indicate that a baceriophage can lysogenize its C difficile host even during the infection process and highlights the importance of lysogeny of C difficile phages as an evolutionary adaptation for survival. (C) 2011 Elsevier Ltd. All rights reserved.

引用

页码：125 / 129

页数：5

共 50 条

[31] MBX-500, a Hybrid Antibiotic with In Vitro and In Vivo Efficacy against Toxigenic Clostridium difficile [J].

Butler, Michelle M. ;

Shinabarger, Dean L. ;

Citron, Diane M. ;

Kelly, Ciaran P. ;

Dvoskin, Sofya ;

Wright, George E. ;

Feng, Hanping ;

Tzipori, Saul ;

Bowlin, Terry L. .

ANTIMICROBIAL AGENTS AND CHEMOTHERAPY, 2012, 56 (09) :4786-4792

[32] In Vivo Physiological and Transcriptional Profiling Reveals Host Responses to Clostridium difficile Toxin A and Toxin B [J].

D'Auria, Kevin M. ;

Kolling, Glynis L. ;

Donato, Gina M. ;

Warren, Cirle A. ;

Gray, Mary C. ;

Hewlett, Erik L. ;

Papin, Jason A. .

INFECTION AND IMMUNITY, 2013, 81 (10) :3814-3824

[33] CD14 expression by human mononuclear phagocytes is modulated by Clostridium difficile toxin B [J].

Siffert, JC ;

Müller, CD ;

Dumont, S ;

Monteil, H ;

Poindron, P .

MICROBES AND INFECTION, 1999, 1 (14) :1159-1162

[34] In Vitro and In Vivo Characterization of CB-183,315, a Novel Lipopeptide Antibiotic for Treatment of Clostridium difficile [J].

Mascio, Carmela T. M. ;

Mortin, Lawrence I. ;

Howland, Karen T. ;

Van Praagh, Andrew D. G. ;

Zhang, Shuxin ;

Arya, Anu ;

Chuong, Cun Lan ;

Kang, Chunfeng ;

Li, Tongchuan ;

Silverman, Jared A. .

ANTIMICROBIAL AGENTS AND CHEMOTHERAPY, 2012, 56 (10) :5023-5030

[35] Plasmids can transfer to Clostridium difficile CD37 and 630Δerm both by a DNase resistant conjugation-like mechanism and a DNase sensitive mechanism [J].

Khodadoost, Ladan ;

Hussain, Haitham ;

Mullany, Peter .

FEMS MICROBIOLOGY LETTERS, 2017, 364 (21)

[36] Safety and Durability of RBX2660 (Microbiota Suspension) for Recurrent Clostridium difficile Infection: Results of the PUNCH CD Study [J].

Orenstein, Robert ;

Dubberke, Erik ;

Hardi, Robert ;

Ray, Arnab ;

Mullane, Kathleen ;

Pardi, Darrell S. ;

Ramesh, Mayur S. .

CLINICAL INFECTIOUS DISEASES, 2016, 62 (05) :596-602

[37] Inhibitory effect of REP3123 on toxin and spore formation in Clostridium difficile, and in vivo efficacy in a hamster gastrointestinal infection model [J].

Ochsner, Urs A. ;

Bell, Stacie J. ;

O'Leary, Ann L. ;

Hoang, Teresa ;

Stone, Kimberley Clawson ;

Young, Casey L. ;

Critchley, Ian A. ;

Janjic, Nebojsa .

JOURNAL OF ANTIMICROBIAL CHEMOTHERAPY, 2009, 63 (05) :964-971

[38] EVALUATION OF THE EFFECTS IN THE IN VITRO SYSTEM OF SYNTHETIC THYMIC HEXAPEPTIDE ON THE EXPRESSION LEVELS OF NF-κB, IFNα/βR AND CD119 NEUTROPHILIC GRANULOCYTES IN PATIENTS WITH CHRONIC HERPES VIRAL CO-INFECTIONS [J].

Nesterova, I., V ;

Khalturina, E. O. ;

Nelyubin, V. N. ;

Khaidukov, S., V ;

Chudilova, G. A. .

INFEKTSIYA I IMMUNITET, 2022, 12 (05) :850-858

[39] Interleukin-22 and CD160 play additive roles in the host mucosal response to Clostridium difficile infection in mice [J].

Akha, Amir A. Sadighi ;

McDermott, Andrew J. ;

Theriot, Casey M. ;

Carlson, Paul E., Jr. ;

Frank, Charles R. ;

McDonald, Roderick A. ;

Falkowski, Nicole R. ;

Bergin, Ingrid L. ;

Young, Vincent B. ;

Huffnagle, Gary B. .

IMMUNOLOGY, 2015, 144 (04) :587-597

[40] Analysis of Anti-Clostridium difficile Activity of Thuricin CD, Vancomycin, Metronidazole, Ramoplanin, and Actagardine, both Singly and in Paired Combinations [J].

Mathur, Harsh ;

O'Connor, Paula M. ;

Hill, Colin ;

Cotter, Paul D. ;

Ross, R. Paul .

ANTIMICROBIAL AGENTS AND CHEMOTHERAPY, 2013, 57 (06) :2882-2886

← 1 2 3 4 5 →